Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder

Acta Psychiatrica Scandinavica

Volumn 118, Issue 2, 2008, Pages 106-115

  Tondo, L ^b,c,d   Lepri, B ^c,d   Baldessarini, R J ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d Lucio Bini Mood Disorder Center   (Italy)

Author keywords

Antidepressants; Bipolar disorders; Depression rating scale; Major depression; Suicidality

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; DULOXETINE; GABAPENTIN; HALOPERIDOL; IMIPRAMINE; LAMOTRIGINE; LITHIUM CARBONATE; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; NOMIFENSINE; OLANZAPINE; OXCARBAZEPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; DISEASE DURATION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HAMILTON SCALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MONOTHERAPY; MOOD DISORDER; POLYPHARMACY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REMISSION; SUICIDE; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SUICIDE; TIME FACTORS; TREATMENT OUTCOME;

EID: 46949091560     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2008.01178.x     Document Type: Article

References (70)

1. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry 1997 170 : 205 228.
2. Kessler RC, Berglund P, Borges G et al. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA 2005 293 : 2487 2495.
3. World Health Organization (WHO). World Health Statistics 2005. Available at: http://www.who.int/mental_health/prevention/suicide/country_reports/en/ index.html, accessed 26 May 2006.
4. Baldessarini RJ, Tondo L Psychopharmacology for suicide prevention. In : Tatarelli R, Pompili M, Girardi P, eds. Suicide in psychiatric disorders. New York : Nova Publishers, 2007 : 193 213.
5. Baldessarini RJ, Tondo L, Strombom I et al. Analysis of ecological studies of relationships between antidepressant utilization and suicidal risk. Harv Rev Psychiatry 2007 15 : 133 145.
6. Ormel J, VonKorff M, Ustun TB et al. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 1994 272 : 1741 1748.
7. Tondo L, Isacsson G, Baldessarini RJ. Suicide in bipolar disorder: risk and prevention. CNS Drugs 2003 17 : 491 511.
8. Lopez AD, Mathers CD, Ezzati M et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006 367 : 1747 1757.
9. Kleinman LS, Lowin A, Flood A et al. Costs of bipolar disorder. Pharmacoeconomics 2003 21 : 601 622.
10. Smit F, Cuijpers P, Oostenbrink J et al. Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ 2006 9 : 193 200.
11. Sobocki P, Jonsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ 2006 9 : 87 98.
12. Corso PS, Mercy JA, Simon TR et al. Medical costs and productivity losses due to interpersonal and self-directed violence in the United States. Am J Prev Med 2007 32 : 474 482.
13. Cuijpers P, Smit F, Oostenbrink J et al. Economic costs of minor depression: population-based study. Acta Psychiatr Scand 2007 115 : 229 236.
14. Yang B, Lester D. Recalculating the economic cost of suicide. Death Studies 2007 31 : 351 361.
15. Baldessarini RJ, Jamison KR. Effects of medical interventions on suicidal behavior: summary and conclusions. J Clin Psychiatry 1999 60 (suppl. 2 117 122.
16. Tondo L, Hennen J, Baldessarini RJ. Reduced suicide risk with long-term lithium treatment in major affective illness: meta-analysis. Acta Psychiatr Scand 2001 104 : 163 172.
17. Baldessarini RJ, Tondo L, Davis P et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 2006 8 : 625 639.
18. Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicidal risk in recurrent major depressive disorder. J Clin Psychiatry 2007 68 : 380 383.
19. Baldessarini RJ, Tondo L. Lithium and suicidal risk: an update. Bipolar Disord 2008 10 : 114 115.
20. Greil W, Ludwig-Mayerhofer W, Erazo N et al. Lithium vs. carbamazepine in the maintenance treatment of bipolar disorders: randomized study. J Affect Disord 1997 43 : 151 161.
21. Bowden CL, Calabrese JR, Sachs G et al. Placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003 60 : 392 400.
22. Calabrese JR, Bowden CL, Sachs G et al. Placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003 64 : 1013 1024.
23. Goodwin FK, Fireman B, Simon GE et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003 290 : 1467 1473.
24. Yerevanian BI, Koeka RJ, Mintz J. Lithium, anticonvulsants and suicidal behavior in bipolar disorder. J Affect Disord 2003 73 : 223 228.
25. Collins JC, McFarland BH. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord 2008 107 : 23 28.
26. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: analysis of the FDA database. Arch Gen Psychiatry 2000 57 : 311 317.
27. Storosum JG, van Zwieten BJ, van den Brink W. et al. Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 2001 158 : 1271 1275.
28. American Psychiatric Association (APA) Task Force, Jacobs D (chairman). APA practice guideline for the assessment and treatment of patients with suicidal behaviors (Part B). Am J Psychiatry 2003 160 (11 suppl 1 44.
29. Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials with SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003 160 : 790 792.
30. Yerevanian BI, Koeck RJ, Feusner JD et al. Antidepressants and suicidal behavior in unipolar depression. Acta Psychiatr Scand 2004 110 : 452 458.
31. Baldessarini RJ. Drug therapy of depression and anxiety disorders. In : Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's the pharmacological basis of therapeutics, 11th edn, Chapter 17. New York : McGraw-Hill, 2005 : 429 459.
32. Fergusson D, Doucette S, Glass KC et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. BMJ 2005 330 : 396 398.
33. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomized controlled trials submitted to the MHRA's safety review. BMJ 2005 330 : 385 388.
34. Tiihonen J, Lonnqvist J, Wahlbeck K et al. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 2006 63 : 1358 1367.
35. Gibbons RD, Brown CH, Hur K et al. Relationship between antidepressants and suicide attempts: analysis of the Veterans Health Administration data sets. Am J Psychiatry 2007 164 : 1044 1049.
36. Medicine and Healthcare Products Regulatory Agency of the UK (MHRA). Safety of Selective Serotonin Reuptake Inhibitor Antidepressants Available at HMRA Website; 2004: http://www.mhra.gov.uk/news/2004/SSRIs_061204.pdf, accessed 20 January 2005.
37. US Food and Drug Administration (FDA). Public Health Advisory: Suicidality in children and adolescents being treated with antidepressant medications (issued 15 October 2004). Available at: http://www.fda.gov/cder/ drug/antidepressants/default.htm (at antidepressant use in children, adolescents, and adults), accessed 9 June 2005.
38. Baldessarini RJ, Pompili M, Tondo L. Suicidal risk in antidepressant trials. Arch Gen Psychiatry 2006 63 : 246 248.
39. Hammad TA, Laughren TP, Racoosin JA. Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacol 2006 26 : 203 207.
40. Hammad TA, Laughren TP, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006 63 : 332 339.
41. Laughren TP. Overview for a meeting of the Psychopharmacology Drug Advisory Committee (PDAC) concerning suicidal risk in trials of antidepressant drugs in juvenile and adult patients. Available at: http://www.fda.gov/ohrms/ dockets/ac/06/briefing/2006-4272b1-index.htm, accessed 26 December 2006.
42. Whittington CJ, Kendall T, Fonagy P et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004 363 : 1341 1345.
43. Usala T, Clavenna A, Zuddas A et al. Randomized controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: systematic review and meta-analysis. Eur Neuropsychopharmacol 2008 18 : 62 73
44. Tsapakis E, Soldani F, Tondo L, Baldessarini RJ. Efficacy of antidepressants in depressed children and adolescents: a meta-analysis. Br J Psychiatry 2008 192 : in press.
45. Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 2003 5 : 421 433.
46. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004 161 : 163 165.
47. Beasley CM Jr, Dornseif BE, Bosomworth JC et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 1991 303 : 685 692.
48. Filteau M-J, Lapierre YD, Bakish D, Blanchard A. Reduction in suicidal ideation with SSRIs: review of 459 depressed patients. J Psychiatry Neurosci 1993 18 : 114 118.
49. Tollefson GD, Rampey AH Jr, Beasley CM Jr et al. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression. J Clin Psychopharmacol 1994 14 : 163 169.
50. Kasper S, Möller HJ, Montgomery SA, Zondag E. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine. Int Clin Psychopharmacol 1995 9 (suppl. 4 3 12.
51. Pedersen AG. Escitalopram and suicidality in adult depression and anxiety. Int Clin Psychopharmacol 2005 20 : 139 143.
52. Acharya N, Rosen AS, Polzer JP et al. Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol 2006 26 : 587 594.
53. Tondo L, Lepri B, Baldessarini RJ. Risks of suicidal ideation, attempts and suicides among 2826 men and women with types I and II bipolar, and recurrent major depressive disorders. Acta Psychiatr Scand 2007 116 : 419 428.
54. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960 23 : 56 62.
55. Tondo L, Baldessarini RH, Floris G. Long-term effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry 2001 178 (suppl. 40 184 190.
56. Akiskal HS, Benazzi F. Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized (bipolar) depressive mixed states? Psychopathology 2005 38 : 273 280.
57. Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf 1993 8 : 186 212.
58. Sonawalla SB, Fava M. Severe depression: is there a best approach? CNS Drugs 2001 15 : 765 776.
59. Papakostas GI, Petersen T, Pava J et al. Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcome. J Nerv Ment Dis 2003 191 : 444 449.
60. Hawton K, Sutton L, Haw C, Sinclair J, Harriss L. Suicide and attempted suicide in bipolar disorder: systematic review of risk factors. J Clin Psychiatry 2005 66 : 693 704.
61. Johnson SL, McMurrich SL, Yates M. Suicidality in bipolar I disorder. Suicide Life Threat Behav 2005 35 : 681 689.
62. Pompili M, Tondo L, Baldessarini RJ. Suicidal risk emerging during antidepressant treatment: recognition and intervention. Clin Neuropsychiatry 2005 2 : 66 72.
63. Valtonen H, Suominen K, Mantere O, Leppämäki S, Arvilommi P, Isometsä ET. Suicidal ideation and attempts in bipolar I and II disorders. J Clin Psychiatry 2005 66 : 1456 1462.
64. Casey PR, Dunn G, Kelly BD et al. Factors associated with suicidal ideation in the general population: five-centre analysis from the ODIN study. Br J Psychiatry 2006 89 : 410 415.
65. McElroy SL, Kotwal R, Kaneria R, Keck PE. Antidepressants and suicidal behavior in bipolar disorder. Bipolar Disord 2006 8 : 596 617.
66. Angst J, Angst F, Gerber-Werder R, Gamma A. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res 2005 9 : 279 300.
67. Meltzer HY, Alphs L, Green AI et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003 60 : 82 91.
68. Hennen J, Baldessarini RJ. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res 2005 73 : 139 145.
69. Perlis RH, Beasley CM, Wines JD et al. Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes. Psychother Psychosom 2007 76 : 40 46.
70. Perlis RH, Purcell S, Fava M et al. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry 2007 64 : 689 697.